MedTrace Logo

Early Prediction of Major Adverse Cardiovascular Events Using Remote Monitoring

NCT03064360 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-07-21

No results posted yet for this study

Summary

Usual care may not identify subtle clinical changes that precede a major adverse cardiovascular event (MACE). Therefore investigators will explore the effectiveness of using biomarkers, patient reported outcomes (PROs), and patient reported informatics (PRIs) as predictors to a MACE event.

Conditions

  • Ischemic Heart Disease

Interventions

OTHER

Laboratory Biomarker Analysis

Blood drawn for biomarker analysis at baseline and study exit. Finger sticks at baseline, interim, and study exit.

DEVICE

Patient Activity

Continuous monitoring of Patient Reported Informatics (PRIs) at study entry to study completion.

BEHAVIORAL

Questionnaires

Symptom and quality of life questionnaire at baseline, and every week following to study completion

Sponsors & Collaborators

  • University of California, Los Angeles

    collaborator OTHER

  • HealthLoop

    collaborator UNKNOWN

  • Neoteryx

    collaborator UNKNOWN

  • California Initiative to Advance Precision Medicine

    collaborator OTHER

  • Cedars-Sinai Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
105 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-13
Primary Completion
2018-01-31
Completion
2020-01-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03064360 on ClinicalTrials.gov